RxDoctor Payments DataLook up a doctor →

Sara Haug, MD

Retina Specialist · Durango, CONPI 1871820837

Payments from drug & device makers

$9,508,906in general payments, 2019–2025

Across 523 payments — averaging $18,181 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$7.9M
  • Genentech, Inc.$1.3M
  • Apellis Pharmaceuticals, Inc.$190K
  • AbbVie$39K
  • F. Hoffmann-la Roche AG$27K
  • Genentech USA, Inc.$23K
  • plus $7K from 8 others
$17,516in research payments, 2019–2025

Across 19 payments — averaging $921.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$11K
  • Janssen Global Services, LLC$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,508,906 in reported general payments places this provider in the 95th percentile of 51 retina specialist providers in Colorado.

See all retina specialist providers in Colorado

Medicare billing

Part B allowed, 2024
$6,092,333
Medicare patients
809
Services billed
103,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Durango

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →